As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) will enable progress in our understanding of the fundamental mechanisms underlying the spread of infectious diseases and the pathogenesis of the diseases they cause. It will also promote new strategies for their control – all within a safe and secure research environment.
UTMB’s researchers and clinicians have considerable specialized expertise in infectious diseases, including tropical and newly emerging viral diseases, as they have been conducting research on emerging infectious diseases for decades. Researchers were actually engaged in biodefense research prior to the anthrax attacks of 2001. Complementing this expertise are scientists in an array of fields who contribute to the biomedical discovery of new drugs and treatments.
In addition to the GNL, UTMB is also home to the first full-size BSL4 lab located on a university campus in the United States. Since 2004, the Robert E. Shope, MD, Laboratory has been safely operated on campus, contributing new knowledge concerning several potentially dangerous virus infections of humans.
Click here to download a full color GNL brochure.